Insulin Like Growth Factor 1 Receptor Market Report

Global and Region Insulin Like Growth Factor 1 Receptor Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：212
  • REPORT CODE：GMM905513
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Insulin Like Growth Factor 1 Receptor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Insulin Like Growth Factor 1 Receptormarket, defines the market attractiveness level of Insulin Like Growth Factor 1 Receptor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Insulin Like Growth Factor 1 Receptor industry, describes the types of Insulin Like Growth Factor 1 Receptor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Insulin Like Growth Factor 1 Receptor market and the development prospects and opportunities of Insulin Like Growth Factor 1 Receptor industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Insulin Like Growth Factor 1 Receptor market in Chapter 13.

    By Player:

    • Astellas Pharma Inc

    • Merck & Co, Inc

    • Immunomedics, Inc

    • Axelar AB

    • Eli Lilly and Company

    • PharmAbcine, Inc

    • ProteoThera, Inc

    • Bristol-Myers Squibb Company

    • Boehringer Ingelheim GmbH

    • Novartis AG

    • AstraZeneca Plc

    • Genmab A/S

    • Insmed Incorporated

    • F Hoffmann-La Roche Ltd

    • Merrimack Pharmaceuticals, Inc

    By Type:

    • BI-893923

    • CT-707

    • 1R-E1

    • ATL-1101

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Insulin Like Growth Factor 1 Receptor Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Insulin Like Growth Factor 1 Receptor Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Insulin Like Growth Factor 1 Receptor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Insulin Like Growth Factor 1 Receptor Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Insulin Like Growth Factor 1 Receptor Market Analysis and Outlook to 2022

    • 7.1 Global Insulin Like Growth Factor 1 Receptor Consumption (2017-2022)

    • 7.2 United States Insulin Like Growth Factor 1 Receptor Consumption (2017-2022)

    • 7.3 Europe Insulin Like Growth Factor 1 Receptor Consumption (2017-2022)

    • 7.4 China Insulin Like Growth Factor 1 Receptor Consumption (2017-2022)

    • 7.5 Japan Insulin Like Growth Factor 1 Receptor Consumption (2017-2022)

    • 7.6 India Insulin Like Growth Factor 1 Receptor Consumption (2017-2022)

    • 7.7 South Korea Insulin Like Growth Factor 1 Receptor Consumption (2017-2022)

    8 Region and Country-wise Insulin Like Growth Factor 1 Receptor Market Analysis and Outlook to 2028

    • 8.1 Global Insulin Like Growth Factor 1 Receptor Consumption Forecast (2022-2028)

    • 8.2 United States Insulin Like Growth Factor 1 Receptor Consumption Forecast (2022-2028)

    • 8.3 Europe Insulin Like Growth Factor 1 Receptor Consumption Forecast (2022-2028)

    • 8.4 China Insulin Like Growth Factor 1 Receptor Consumption Forecast (2022-2028)

    • 8.5 Japan Insulin Like Growth Factor 1 Receptor Consumption Forecast (2022-2028)

    • 8.6 India Insulin Like Growth Factor 1 Receptor Consumption Forecast (2022-2028)

    • 8.7 South Korea Insulin Like Growth Factor 1 Receptor Consumption Forecast (2022-2028)

    9 Global Insulin Like Growth Factor 1 Receptor Market Outlook by Types and Applications to 2022

    • 9.1 Global Insulin Like Growth Factor 1 Receptor Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global BI-893923 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CT-707 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global 1R-E1 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ATL-1101 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Insulin Like Growth Factor 1 Receptor Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Insulin Like Growth Factor 1 Receptor Market Outlook by Types and Applications to 2028

    • 10.1 Global Insulin Like Growth Factor 1 Receptor Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global BI-893923 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CT-707 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global 1R-E1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global ATL-1101 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Insulin Like Growth Factor 1 Receptor Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Insulin Like Growth Factor 1 Receptor Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Insulin Like Growth Factor 1 Receptor Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Insulin Like Growth Factor 1 Receptor Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Insulin Like Growth Factor 1 Receptor Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Insulin Like Growth Factor 1 Receptor Market Competitive Analysis

    • 14.1 Astellas Pharma Inc

      • 14.1.1 Astellas Pharma Inc Company Details

      • 14.1.2 Astellas Pharma Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Astellas Pharma Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.2 Merck & Co, Inc

      • 14.2.1 Merck & Co, Inc Company Details

      • 14.2.2 Merck & Co, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck & Co, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.3 Immunomedics, Inc

      • 14.3.1 Immunomedics, Inc Company Details

      • 14.3.2 Immunomedics, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Immunomedics, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.4 Axelar AB

      • 14.4.1 Axelar AB Company Details

      • 14.4.2 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Axelar AB Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.5 Eli Lilly and Company

      • 14.5.1 Eli Lilly and Company Company Details

      • 14.5.2 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.6 PharmAbcine, Inc

      • 14.6.1 PharmAbcine, Inc Company Details

      • 14.6.2 PharmAbcine, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 PharmAbcine, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.7 ProteoThera, Inc

      • 14.7.1 ProteoThera, Inc Company Details

      • 14.7.2 ProteoThera, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 ProteoThera, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.8 Bristol-Myers Squibb Company

      • 14.8.1 Bristol-Myers Squibb Company Company Details

      • 14.8.2 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.9 Boehringer Ingelheim GmbH

      • 14.9.1 Boehringer Ingelheim GmbH Company Details

      • 14.9.2 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.10 Novartis AG

      • 14.10.1 Novartis AG Company Details

      • 14.10.2 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis AG Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.11 AstraZeneca Plc

      • 14.11.1 AstraZeneca Plc Company Details

      • 14.11.2 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.12 Genmab A/S

      • 14.12.1 Genmab A/S Company Details

      • 14.12.2 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.13 Insmed Incorporated

      • 14.13.1 Insmed Incorporated Company Details

      • 14.13.2 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.14 F Hoffmann-La Roche Ltd

      • 14.14.1 F Hoffmann-La Roche Ltd Company Details

      • 14.14.2 F Hoffmann-La Roche Ltd Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 F Hoffmann-La Roche Ltd Insulin Like Growth Factor 1 Receptor Product and Service

    • 14.15 Merrimack Pharmaceuticals, Inc

      • 14.15.1 Merrimack Pharmaceuticals, Inc Company Details

      • 14.15.2 Merrimack Pharmaceuticals, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Merrimack Pharmaceuticals, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Insulin Like Growth Factor 1 Receptor

    • Figure Insulin Like Growth Factor 1 Receptor Picture

    • Table Global Insulin Like Growth Factor 1 Receptor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Insulin Like Growth Factor 1 Receptor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Insulin Like Growth Factor 1 Receptor Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Insulin Like Growth Factor 1 Receptor Consumption by Country (2017-2022)

    • Figure United States Insulin Like Growth Factor 1 Receptor Consumption and Growth Rate (2017-2022)

    • Table Europe Insulin Like Growth Factor 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure China Insulin Like Growth Factor 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure Japan Insulin Like Growth Factor 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure India Insulin Like Growth Factor 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure South Korea Insulin Like Growth Factor 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Like Growth Factor 1 Receptor Consumption Forecast by Country (2022-2028)

    • Figure United States Insulin Like Growth Factor 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Insulin Like Growth Factor 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Insulin Like Growth Factor 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Insulin Like Growth Factor 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Insulin Like Growth Factor 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Insulin Like Growth Factor 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BI-893923 Consumption and Growth Rate (2017-2022)

    • Figure Global CT-707 Consumption and Growth Rate (2017-2022)

    • Figure Global 1R-E1 Consumption and Growth Rate (2017-2022)

    • Figure Global ATL-1101 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global BI-893923 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CT-707 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 1R-E1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ATL-1101 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Insulin Like Growth Factor 1 Receptor Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Insulin Like Growth Factor 1 Receptor Export by Region (Top 5 Countries) (2017-2028)

    • Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Immunomedics, Inc (Foundation Year, Company Profile and etc.)

    • Table Immunomedics, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunomedics, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Axelar AB (Foundation Year, Company Profile and etc.)

    • Table Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Axelar AB Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product and Service

    • Table PharmAbcine, Inc (Foundation Year, Company Profile and etc.)

    • Table PharmAbcine, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table PharmAbcine, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • Table ProteoThera, Inc (Foundation Year, Company Profile and etc.)

    • Table ProteoThera, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table ProteoThera, Inc Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Insulin Like Growth Factor 1 Receptor Product and Service

    • Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Genmab A/S (Foundation Year, Company Profile and etc.)

    • Table Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genmab A/S Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Insmed Incorporated (Foundation Year, Company Profile and etc.)

    • Table Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Insulin Like Growth Factor 1 Receptor Product and Service

    • Table Merrimack Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Merrimack Pharmaceuticals, Inc Insulin Like Growth Factor 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merrimack Pharmaceuticals, Inc Insulin Like Growth Factor 1 Receptor Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US